ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01123304
Recruitment Status : Terminated (This study has been terminated due to lack of availability of investigational product.)
First Posted : May 14, 2010
Last Update Posted : July 17, 2014
Sponsor:
Information provided by (Responsible Party):
Morphotek

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : March 2012